ESC Professional Premium Access

Lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers – the final word.

Congress Session

2 more presentations in this session

Lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers: pro.

Speaker: Professor S. Nicholls (Melbourne, AU)

Thumbnail

Lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers: con.

Speaker: Professor C. Baigent (Oxford, GB)

Thumbnail

Access the full session

Great Debate: lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers

Speakers: Professor S. Nicholls, Professor C. Baigent
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk